Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pure Green CBD tablets in diabetic neuropathic pain
NCT04088929Phase 2Completed
- Sponsor
- Pure Green Pharmaceuticals
- Start
- Sep 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in diabetic peripheral neuropathy (DPN), sponsored by Pure Green Pharmaceuticals. Started Sep 2019; status: completed.
02
Drugs
cannabidiol
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04088929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088929.